Involvement of CX3CL1/CX3CR1 axis in etanercept therapy for patients with active rheumatoid arthritis

Involvement of CX3CL1/CX3CR1 axis in etanercept therapy for patients with active rheumatoid arthritis

Michihito Sato, Kumiko Ohtsuka, Ryo Takahashi, Kuninobu Wakabayashi, Tsuyoshi Odai, Takeo Isozaki, Nobuyuki Yajima, Yusuke Miwa, Tsuyoshi KasamaDivision of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, JapanObjective: To examine the relationship between serum chem...

Full description

Bibliographic Details
Main Authors:	Michihito Sato, Kumiko Ohtsuka, Ryo Takahashi, et al
Format:	Article
Language:	English
Published:	Dove Medical Press 2011-01-01
Series:	Open Access Rheumatology : Research and Reviews
Online Access:	http://www.dovepress.com/involvement-of-cx3cl1cx3cr1-axis-in-etanercept-therapy-for-patients-wi-a6025

Similar Items

The Impact of the CX3CL1/CX3CR1 Axis in Neurological Disorders
by: Paulina Pawelec, et al.
Published: (2020-10-01)

Role of CX3CL1/CX3CR1 Signaling Axis Activity in Osteoporosis
by: Piotr Wojdasiewicz, et al.
Published: (2019-01-01)

CX3CL1–CX3CR1 Axis: A New Player in Coeliac Disease Pathogenesis
by: Marta Fernández-Prieto, et al.
Published: (2019-10-01)

Modulating neurotoxicity through CX3CL1/CX3CR1 signaling
by: Cristina eLimatola, et al.
Published: (2014-08-01)

CX3CL1/CX3CR1 in Alzheimer’s Disease: A Target for Neuroprotection
by: Peiqing Chen, et al.
Published: (2016-01-01)

Early activation of the cardiac CX3CL1/CX3CR1 axis delays β-adrenergic-induced heart failure
by: M. Flamant, et al.
Published: (2021-09-01)

Involvement of CX3CL1/CX3CR1 signaling in spinal long term potentiation.
by: Chao Bian, et al.
Published: (2015-01-01)

Hydrogen sulfide inhibits the development of atherosclerosis with suppressing CX3CR1 and CX3CL1 expression.
by: Huili Zhang, et al.
Published: (2012-01-01)

Proteolysis of CX3CL1 Impacts CX3CR1 Signaling and Therapeutic Benefits in a Tauopathy Model
by: Finneran, Dylan John
Published: (2018)

Prevention of lipopolysaccharide-induced preterm labor by the lack of CX3CL1-CX3CR1 interaction in mice.
by: Mika Mizoguchi, et al.
Published: (2018-01-01)

Microglia and Aging: The Role of the TREM2–DAP12 and CX3CL1-CX3CR1 Axes
by: Carmen Mecca, et al.
Published: (2018-01-01)

Tenophages: a novel macrophage-like tendon cell population expressing CX3CL1 and CX3CR1
by: Christine Lehner, et al.
Published: (2019-12-01)

Fractalkine (CX3CL1) and Its Receptor CX3CR1 May Contribute to Increased Angiogenesis in Diabetic Placenta
by: Dariusz Szukiewicz, et al.
Published: (2013-01-01)

Dynamic changes of CX3CL1/CX3CR1 axis during microglial activation and motor neuron loss in the spinal cord of ALS mouse model
by: Jingjing Zhang, et al.
Published: (2018-12-01)

Correction: CX3CR1 Is Expressed by Human B Lymphocytes and Mediates CX3CL1 Driven Chemotaxis of Tonsil Centrocytes
by: Anna Corcione, et al.
Published: (2010-01-01)

CX3CL1/CX3CR1 and CCL2/CCR2 chemokine/chemokine receptor complex in patients with AMD.
by: Mads Krüger Falk, et al.
Published: (2014-01-01)

CX3CR1 is expressed by human B lymphocytes and mediates [corrected] CX3CL1 driven chemotaxis of tonsil centrocytes.
by: Anna Corcione, et al.
Published: (2009-12-01)

Fractalkine (CX3CL1) and Its Receptor CX3CR1: A Promising Therapeutic Target in Chronic Kidney Disease?
by: Sarah Cormican, et al.
Published: (2021-06-01)

Corrigendum to “Comparative Analysis of the Occurrence and Role of CX3CL1 (Fractalkine) and Its Receptor CX3CR1 in Hemophilic Arthropathy and Osteoarthritis”
by: Piotr Wojdasiewicz, et al.
Published: (2020-01-01)

High Glucose Level Disturbs the Resveratrol-Evoked Curtailment of CX3CL1/CX3CR1 Signaling in Human Placental Circulation
by: Dariusz Szukiewicz, et al.
Published: (2017-01-01)

Synergistic induction of CX3CL1 by TNF alpha and IFN gamma in osteoblasts from rheumatoid arthritis: involvement of NF-kappa B and STAT-1 signaling pathways
by: Kuninobu Wakabayashi, et al.
Published: (2008-10-01)

CCL2/CCR2 and CX3CL1/CX3CR1 chemokine axes and their possible involvement in age-related macular degeneration
by: Camelo Serge, et al.
Published: (2010-12-01)

Platelets are recruited to hepatocellular carcinoma tissues in a CX3CL1‐CX3CR1 dependent manner and induce tumour cell apoptosis
by: Shuo Miao, et al.
Published: (2020-10-01)

Fractalkine/CX3CL1 in Neoplastic Processes
by: Jan Korbecki, et al.
Published: (2020-05-01)

Two forms of CX3CL1 display differential activity and rescue cognitive deficits in CX3CL1 knockout mice
by: Aimee N. Winter, et al.
Published: (2020-05-01)

CX3CL1/CX3CR1 axis attenuates early brain injury via promoting the delivery of exosomal microRNA-124 from neuron to microglia after subarachnoid hemorrhage
by: Xiao Chen, et al.
Published: (2020-07-01)

Etude du signal AMP cyclique déclenché par la chimiokine CX3CL1 en aval de son récepteur CX3CR1
by: Felouzis, Virginia
Published: (2015)

Role of the CX3C chemokine receptor CX3CR1 in the pathogenesis of atherosclerosis after aortic transplantation.
by: Zuzanna Rowinska, et al.
Published: (2017-01-01)

Putative Eisenregulation von Fractalkin (CX3CL1), pathophysiologische Rolle von CX3CL1 in Plättchenmodellen und Eisenhaushalt in der Megakaryopoese
by: Breyer, Charles Pierre Paul
Published: (2021)

Microglia, seen from the CX3CR1 angle
by: Yochai eWolf, et al.
Published: (2013-03-01)

Modulation of fractalkine receptor (CX3CR1) activation
by: Tan, Thomas Chin Che
Published: (2011)

High expression of CX3C chemokine receptor 1 (CX3CR1) in human carotid plaques is associated with vulnerability of the lesions
by: Marta Masztalewicz, et al.
Published: (2017-06-01)

CX3CL1 promotes MMP-3 production via the CX3CR1, c-Raf, MEK, ERK, and NF-κB signaling pathway in osteoarthritis synovial fibroblasts
by: Sheng-Mou Hou, et al.
Published: (2017-12-01)

CX<sub>3</sub>CL1 (fractalkine) and CX<sub>3</sub>CR1 expression in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis: kinetics and cellular origin
by: Olsson Tomas, et al.
Published: (2005-07-01)

Sirtuin 3 promotes microglia migration by upregulating CX3CR1
by: Runjing Cao, et al.
Published: (2019-01-01)

The CX3C-Chemokine Fractalkine (CX3CL1) is Detectable in Serum of Patients Affected by the Inflammatory Diseases Allergic Rhinitis and/or Asthma
by: P.L. Minciullo, et al.
Published: (2005-09-01)

Fractalkine/CX3CR1 Pathway in Neuropathic Pain: An Update
by: Rita Silva, et al.
Published: (2021-07-01)

Absence of CX3CR1 impairs the internalization of Tau by microglia
by: Marta Bolós, et al.
Published: (2017-08-01)

Fractalkine/CX3CR1 signalling during neuropathic pain
by: Anna K Clark, et al.
Published: (2014-05-01)

The Role of CX3CR1 Signaling in Alzheimer's Disease Pathogenesis
by: Lee, Sungho
Published: (2013)

Cannot write session to /tmp/vufind_sessions/sess_nc8ut7tmr70hns5ud6flvbmh5l